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Abstract Capnocytophga canimorsus and Capnocytophga
cynodegmi can be transmitted from cats and dogs to humans,
and can cause a wide range of infections including wound
infections, sepsis, or endocarditis. We and others recently dis-
covered two new Capnocytophaga species, C. canis and
C. stomatis, mainly associated with wound infections. The
first-line treatment of animal bite related infections is penicil-
lin, and in case of allergy, doxycycline and trimethoprim/sul-
famethoxazole. However, there is a lack of antibiotic suscep-
tibility patterns for animal bite associated Capnocytophaga
species. Thus, we set out to study the antibiotic profiles
against animal bite associatedCapnocytophaga species isolat-
ed from wound and blood cultures after cat and dog bites and
coupled the findings to whole genome sequencing data. A
total of 24 strains were included in the study. Phenotypic anal-
ysis of antibiotic resistance was performed with E-tests. The
web-based tool ‘Resfinder’ was used to identify resistance
genes in the whole genome dataset. Two strains of
C. cynodegmi and two strains of the recently discovered
C. stomatis were resistant to penicillin (MIC > 24 mg/L) and
cephalosporins (MIC > 24 mg/L), and three out of these
strains also exhibited resistance to imipenem (MIC = 32 mg/
L). Genomic analysis revealed that these strains carried a class
D beta-lactamase gene, which has not previously been found
in Capnocytophaga spp. A class D beta lactamase with broad
substrate specificity was found in animal bite associated
Capnocytophaga species, which could have important impli-
cations when treating wound infections after cat and dog bites.
It also suggests that pet animal bacteria can harbour resistance
genes with relevance for human infections.
Introduction
Capnocytophaga canimorsus and Capnocytophaga
cynodegmi normally reside in the oral flora of healthy cats
and dogs, but can be transmitted to humans via bites or
scratches.C. canimorsus can cause wound infections, but also
invasive infections, including sepsis, meningitis, or endocar-
ditis [4], whereas C. cynodegmi has mostly been associated
with wound infections [9, 13, 23]. Recently, an additional
Capnocytophaga species named Capnocytophaga canis
was found in the oral flora of healthy dogs [22]. In addition,
we also recently described a fourth animal-associated
Capnocytophaga species that was given the name
Capnocytophaga stomatis [26]. The pathogenic potential of
C. canis is unknown, whereas C. stomatis was found in a
wound specimen from a dog bite [26].
The treatment of wound infections after cat- and dog-bites
involves cleaning and debridation and also antibiotics as pre-
vention or treatment, unless the wound is superficial. For dog-
bites, the first-line treatment is amoxicillin+clavulanic acid,
and for cat-bites the first-line therapy is penicillin [12]. If the
patient is allergic to penicillin, the recommendation is trimeth-
oprim–sulfametoxazol or doxycycline [21]. Clindamycin or
daily injections with ceftriaxone—in cases of low compli-
ance—have been proposed [15]. These antibiotics are consid-
ered to cover the most common bacteria related to cat and dog
bites, including Pasteurella, Staphylococcus, Streptococcus as
well as anaerobic Fusobacteria spp. and Bacteroides fragilis.
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In addition, the suggested empirical treatment is thought to
cover for C. canimorsus and C. cynodemi [20].
However, available data on antibiotic susceptibility testing
(AST) is scarce for C. canimorsus and C. cynodegmi. The
related human Capnocytophaga spp., which are found in the
oral flora of healthy individuals, are usually susceptible to
penicillin. However, penicillin resistance also occurs in these
bacteria, and some reports have described beta-lactamase pro-
duction among clinical isolates of human Capnocytophaga
spp., including C. sputigena and C. ochracea [10, 17].
However, whether animal-associated Capnocytophaga spe-
cies produce beta-lactamases is not known.
Thus, given the lack of available AST data, we set out
to describe the phenotypic susceptibility patterns for the
strains in our collection to a range of clinically relevant anti-
biotics. Our strain collection included C. canimorsus and
C. cynodegmi as well as the novel Capnocytophaga species
C. canis and C. stomatis. In order to obtain a mechanistic
understanding of the phenotypic results, we coupled the




In total, 24 isolates were included in the study, including n = 9
C. canimorsus, n = 9C. cynodegmi, n = 3C. stomatis and n = 1
C. canis, and n = 2 reference strains (C. canimorsus, ATCC
35978 and C. cynodegmi, ATCC 49045). C. canis was isolat-
ed from a human wound specimen, and is thus here defined as
a clinical isolate. These isolates have been described in detail
in previous studies from our group [26–28]. The genomes for
all 24 strains were used in the bioinformatic analyses, whereas
16 strains were subjected to antibiotic susceptibility testing
based on consistent and reproducible growth patterns.
Reagents
Horse blood agar plates (HBA) and phosphate buffered
saline (PBS) were manufactured by the Substrate Unit at
KarolinskaUniversity Hospital, Stockholm, Sweden, which
is accredited by the Swedish Board for Accreditation and
Conformity Assessment (SWEDAC).
Antibiotic susceptibility testing by E-test
The Etest (Biomerieux) was used to determine the minimal
inhibitory concentration (MIC) against a range of clinically
relevant antibiotics: cefotaxime, gentamicin, oxacillin, ceftaz-
idime, imipenem, clindamycin, doxycycline, tigecycline,
erythromycin, benzyl penicillin (PcG) and amoxicillin–
clavulanate (amox/clav). Briefly, bacteria were thawed from
stocks and sub-cultured on HBA plates, incubated at 35 °C in
5% CO2 for 48 hours. Thereafter, a loop of bacteria was
suspended in sterile PBS to an optical density of McFarland
0.5 × 108 CFU/ml [18], and spread on blood agar plates im-
mediately prior to the application of the E-test strips [11].
Plates were incubated at 35 °C in 5% CO2 for 48 hours before
reading the results. MIC values were interpreted according to
the EUCAST antimicrobial guidelines for non-species-related
breakpoints [19].
Identification of antibiotic resistance genes
The software tool ResFinder from the Center for Genomic
Epidemiology was used for identification of antimicrobial re-
sistance genes in the genomic sequences of 24 strains of
Capnocytophaga spp. FASTA files of complete genomes for
all strains were used as search strings in the program. The
threshold for ID was set to 98% and the minimum length
was set to 60% [29].
Phylogenetic analysis
The phylogenetic tree of the various beta-lactamases was con-




Given the lack of knowledge on antibiotic resistance in animal
bite associated Capnocytophaga species, we determined the
minimal inhibitory concentrations (MIC) of the strains in our
collection (n = 16) (Table 1). Importantly, all C. canimorsus
strains, obtained from blood cultures, were susceptible to pen-
icillin (MIC 0.025–2 mg/l), which is the recommended first
choice in relation to dog and cat bite wounds [12]. Likewise,
the C. canimorsus strains were susceptible to cefotaxime and
ceftazidime as well as to imipenem, which all are common
clinical choices in case of sepsis with unknown cause.We also
included several strains that were isolated from wounds.
Interestingly, four wound-associated strains (W5, W6, W7,
and W10) were resistant to penicillin and cephalosporins,
and three of these strains also exhibited a high MIC value
for imipenem, suggesting the presence of a beta-lactamase
with broad substrate specificity. Notably, these four strains,
of which two belonged to C. cynodegmi and two belong to
the recently described C. stomatis, were also resistant to
amoxicillin+clavulanic acid and negative for cefinase activity
(Table 1).
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Searching for antibiotic resistance genes using whole
genome data
Since we previously performed whole genome sequencing of
these strains, we set out to search for antibiotic resistance
genes that could explain the phenotypic results for strains
W5, W6, W7, and W10. To this end, we used the web-based
program ResFinder, which demonstrated the presence of a
class D beta-lactamase in two strains of C. cynodegmi and
two strains of C. stomatis (Table 2). The gene was designated
‘blaOXA-347’ and showed 100% identity between the four
strains, indicating a common origin. In addition, the tetracy-
cline resistance gene ‘tet(X)’was found inW6 andW7, which
was in line with the phenotypic data in Table 1.
Phylogenetic analysis of blaOXA-347
The class D beta-lactamase gene family is large and diverse
[8]. Thus, we set out to analyse the relationship between
blaOXA-347 and other class D beta-lactamases utilizing a
web-based program [29]. This analysis resulted in a phyloge-
netic tree, which clearly showed that the Capnocytophaga
sequences clustered uniformly (100% sequence identity) and
were related to several beta-lactamases of clinical importance,
including ‘blaOXA48’ [8] (Fig. 1).
Discussion
Here we set out to describe the antibiotic susceptibility pat-
terns of a collection of animal bite associatedCapnocytophaga
isolates, including the recently discovered C. canis and
C. stomatis. In addition, we linked the phenotypic results
with full genome sequences obtained in a previous project
[26]. A major finding in this work is the identification of a
beta-lactamase in four strains of animal bite associated
Capnocytophaga species. This enzyme, designated
blaOXA347, is associated with phenotypic resistance to
Table 1 Phenotypic antibiotic susceptibility results for C. canimorsus (Cani), C.cynodegmi (Cyno), C. canis and C. cynodegmi. Red colour denotes
resistant phenotypes. Squares marks isolates with confirmed genomic presence of blaOXA-347. B, isolates obtained from blood cultures; W, isolates
obtained from wound cultures
Cefotaxim Gentamicin Oxacillin Ceftazidim Imipenem Trim/sulfa Clindamycin Doxycyclin Tigecycline Erytromycin PcG Amox/cla
Cani ATCC 1 256 32 12 1 32 0,016 0,5 0,064 0,25 0,05
Cyno ATCC 0,125 256 8 2 2 32 0,064 1 0,25 2 0,5
B1 Cani 1 256 12 12 0,5 4 0,016 0,25 0,032 0,032 0,032
B2 Cani 0,5 256 12 8 1 32 0,016 0,25 0,032 0,125 0,032
B3 Cani 0,5 256 12 8 1 0,25 0,016 0,5 0,064 0,25 0,032
B5 Cani 0,5 256 12 4 1 32 0,032 0,5 0,125 0,5 0,032
B8 Cani 0,5 256 8 2 4 32 0,016 0,5 0,064 0,5 0,032
W1 Cyno 0,25 256 8 1 8 32 0,032 0,25 0,125 1 0,25
W4 Cyno 0,064 256 2 1 1 32 0,064 0,5 0,125 2 0,25
W5 Stomatis 48 256 256 256 32 32 0,016 6 0,016 0,5 64(128) 12
W6 Cyno 256 256 256 256 2 12 0,064 4 1 0,5 48(48) 6
W7 Stomatis 24 256 256 256 32 32 0,016 4 1 0,5 32(32) 6
W9 Cyno 8 256 64 32 2 32 0,016 0,25 0,125 1 0,25
W10 Cyno 64 256 256 256 32 32 0,064 0,25 0,25 1 24(64) 16
W12 Stomatis 0,25 256 4 0,25 2 32 0,016 0,125 0,125 0,25 0,125
W13 Canis 4 256 48 32 0,5 32 0,016 0,25 0,125 0,25 0,5
Table 2 Results for identified
resistance genes in C. cynodegmi
and C. stomatis by Resfinder
Bacteria ID Resistance gene % identity Query/HSP length Predicted phenotype
W5
C. stomatis
blaOXA-347 100.00 825/825 Beta-lactam resistance
W6
C. cynodegmi
blaOXA-347 100.00 825/825 Beta-lactam resistance
tet(X) 89.55 1,167/1,167 Tetracycline resistance
W7
C. stomatis
blaOXA-347 100.00 825/825 Beta-lactam resistance
tet(X) 89.55 1,167/1,167 Tetracycline resistance
W10
C. cynodegmi
blaOXA-347 100.00 825/825 Beta-lactam resistance
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penicillin, cephalosporins, and also to imipenem. Given this
broad substrate specificity, it could indeed be classified as a
carbapenemase [8]. Notably, blaOXA347 was only found in
wound-associated strains and not in blood culture isolates,
suggesting a possible negative effect on virulence and fitness.
The enzyme also appears to be connected to the bacterial chro-
mosome and not found on a plasmid, which significantly
lowers the transmission potential to other Capnocytophaga
strains. However, the fact that the gene is 100% identical at
the nucleotide level in the four strains that represent two dif-
ferent species indicates that it has been horizontally
transferred.
It is possible that commensal bacteria in the oral flora of
cats and dogs serve as a reservoir for antibiotic resistance
genes. In humans, for example, Capnocytophaga species
(C. ochracea, C. sputigena) are often resistant to penicillin
and cephalosporins by virtue of several different beta-
lactamases [6, 10]. In line with this analogy, it is possible that
blaOXA347 could be transmitted via transposons to the more
virulent and invasive C. canimorsus, although no such multi-
drug resistant C. canimorsus have been described. Notably,
this mechanism of transmission was recently shown for the
chromosomally encoded blaNDM-1 carbapenemase gene in
Acinetobacter baumanii [14] and OXA48 carbapenemase in
highly virulent E. coli [2].
Interestingly, a BLAST search revealed that blaOXA347
has a 100% homology to a beta-lactamase in Myroides
odoratimimus (data not shown). This is an environmental
gram-negative bacteria found in soil and water, which in rare
cases may cause infections in immunocompromised individ-
uals [7]. M. odoratimimus is commonly resistant to beta-
lactams, including cephalosporins and carbapenems [16].
Several chromosomally encoded beta-lactamases have been
described in this bacterial species [1], and it is possible that
it has transmitted blaOXA347 to bacteria in the dog oral flora,
although this remains to be proven.
Fig. 1 A phylogenetic tree of the
beta lactamases showing the
relationship between the
candidate sequence and other beta
lactamases
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In addition, a neighbour in the phylogenetic tree is
Schewanella algae, a non-fermentative, gram negative oppor-
tunistic bacteria, which may cause skin and soft-tissue infec-
tions in immunocompromised individuals. Schewanella algae
has also been shown to be resistant to cefalosporins and to
imipenem [24]. In addition, whole genome sequencing has
demonstrated the presence of several beta-lactamases in the
S. algae genome [5]. Thus, it is possible that the environmen-
tal bacteriaM. odoratimimus and S. algaemay have transmit-
ted blaOXA-347 to C. cynodegmi and C. stomatis in the oral
flora of cats and dogs.
This study has several strengths. First, it is the most up-
dated and largest analysis of antibiotic susceptibility in animal
bite associatedCapnocytophaga species inmore than 25 years
[3, 25]. Second, we have included the recently discovered
novel species C. canis and C. stomatis, for which there is
no data on antibiotic susceptibility available. Notably,
blaOXA347 was found in two isolates of C. stomatis, which
make this species a focus for future studies in the area of
bacterial resistance. Finally, we have combined detailed phe-
notypic testing with whole genome analysis, which has not
previously been performed for Capnocytophaga species.
There are also several weak points. Although the study
includes 24 isolates (whole genomes) and 16 isolates (pheno-
typic analysis), it is a small study compared to studies
on many other bacterial species. This has to be taken into
account when interpreting the data, and the full picture of
the epidemiology of blaOXA347 in animal bite associated
Capnocytophaga species remains to be shown. Another
limitation includes the bioinformatic analysis, which was per-
formed utilizing the web-based program ResFinder.
Interestingly, ResFinder rapidly identified blaOXA347 and
tet(X) in several isolates. However, the phenotypic antibiotic
resistance patterns indicated that there are several additional
resistance genes encoded in the genomes of these bacteria.
Taken together, this discrepancy indicates that more detailed
bioinformatic work needs to be done to describe the full
resistome on the genome level. Until efficient and easy-to-
use bioinformatics tools are readily available for clinicians,
phenotypic testing will still have a place in the clinical
laboratory.
It is noteworthy that all C. canimorsus strains tested had a
very low MIC value for penicillin, the first-line drug for in-
fections after cat or dog-bites. This finding is in line with
previous studies [3, 25]. Based on our data (Table 1), penicil-
lin or cephalosporins or in the case of type I allergy to PC,
clindamycin or tetracycline appear to be effective against in-
vasive infections with C. canimorsus. For wound infections,
the situation is more complex, and there is broad resistance to
beta-lactams in four isolates. However, no resistance to
clindamycin was found, and tetracycline appears to be a good
alternative. Thus, we suggest that clinicians become aware of
the possibility of beta-lactam resistance in wound-associated
Capnocytophaga species, and that full AST is performed in
case of animal bite associated wounds. Likewise, the presence
of a beta-lactam resistant C. canimorsus is unlikely, but—giv-
en the current data—a future possibility, which needs to be
considered in clinical bacteriological laboratories. This is
particularly important, since Capnocytophaga are fastidious
bacteria that grow slowly and can be difficult to identify, es-
pecially in wound specimens where a polymicrobial flora
dominates.
To conclude, we demonstrated the antibiotic susceptibility
profile of clinical Capnocytophaga isolates, and have identi-
fied a chromosomally encoded betalactamase (blaOXA347)
with broad substrate specificity in animal associated
Capnocytophaga species. This is a novel finding, and points
to a role of the normal flora of pet animals as a reservoir of
bacterial resistance genes, although the clinical relevance
remains to be established. We suggest that further research
is warranted in order to obtain more knowledge on the
epidemiology, bacterial resistance, and clinical outcomes of
Capnocytophaga infections.
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